Vanderbilt Scientists Discover How Gut Pathogen Rewires Metabolism to Fuel Colorectal Cancer and Diarrhea

Vanderbilt researchers reveal how ETBF bacteria manipulate intestinal oxygen levels to fuel growth, driving inflammation and colorectal cancer development.

By: AXL Media

Published: May 1, 2026, 9:02 AM EDT

Source: Information for this report was sourced from EurekAlert!

The Biological Hijacking of Intestinal Nutrient Streams

A specialized pathogen known as enterotoxigenic Bacteroides fragilis, or ETBF, has been found to act as a metabolic architect within the human gut. According to findings published in the journal Cell, this microbe does not merely survive in the intestine but actively reshapes the biological landscape to secure the resources it needs. By deploying a specific toxin, the pathogen forces host cells to alter their internal chemistry, effectively turning the gut into a specialized feeding ground. This discovery by Vanderbilt Health researchers suggests that microbes previously thought to be passive participants in inflammation are actually the primary drivers of the process.

Challenging the Scientific Dogma of Anaerobic Survival

The study fundamentally disrupts the traditional understanding of how anaerobic bacteria interact with oxygen. While ETBF is classified as a classic anaerobe that typically thrives in low-oxygen environments, lead author Wenhan Zhu, PhD, notes that the pathogen surprisingly thrives by creating an oxygen-rich niche. The toxin produced by the bacteria reduces the oxygen consumption of intestinal epithelial cells, which in turn leaves more oxygen available for the pathogen to utilize. This counterintuitive mechanism allows the bacteria to outcompete other microbes in the densely populated and highly competitive environment of the human digestive tract.

The Direct Link Between Metabolic Shifts and Colorectal Malignancy

The metabolic reprogramming initiated by ETBF carries severe long-term health implications, particularly regarding the onset of colorectal cancer. By manipulating immune signaling pathways and bile acid biology, the pathogen fosters a microbial community that is consistently associated with the formation of tumors. The research indicates that the resulting oxidative stress and inflammation are not just side effects of the infection but are strategic environmental modifications. These changes specifically promote the growth of disease-associated communities, providing a clearer roadmap for how chronic bacterial colonization can eventually transition into malignant disease.